There is increasing intervention activities provided during pharmacist-led diabetes management. Nevertheless, there is an unclear definition of the activities involved during the intervention. Thus, this study aimed to describe the type of intervention strategies and service model provided during pharmacist-led type 2 diabetes management and service outcomes.
Methods
This study utilized the scoping review methodology of the Joanna Briggs Institute Reviewers’ Manual 2015. Articles on pharmacist-led diabetes management focusing on the service content, delivery methods, settings, frequency of appointments, collaborative work with other healthcare providers, and reported outcomes were searched and identified from four electronic databases: Ovid Medline, PubMed, Scopus, and Web of Science from 1990 to October 2020. Relevant medical subject headings and keywords, such as “diabetes,” “medication adherence,” “blood glucose,” “HbA1c,” and “pharmacist,” were used to identify published articles.
Results
The systematic search retrieved 4,370 articles, of which 61 articles met the inclusion criteria. The types of intervention strategies and delivery methods were identified from the studies based on the description of activities reported in the articles and were tabulated in a summary table.
Conclusion
There were variations in the descriptions of intervention strategies, which could be classified into diabetes education, medication review, drug consultation/counseling, clinical intervention, lifestyle adjustment, self-care, peer support, and behavioral intervention. In addition, most studies used a combination of two or more intervention strategy categories when providing services, with no specific pattern between the service model and patient outcomes.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Background
The prevalence of diabetes is increasing worldwide [1]. The prevalence of diabetes in the developed and developing countries is expected to increase by 42% and 170%, respectively, by 2030 [2]. This is particularly a concern in developing countries, as they are commonly affected by rapid population growth, an aging community, unhealthy local diet, urbanization, obesity, unhealthy lifestyle, and poor access to quality health care [3]. As these problems arise, the cost of managing the illness increases. The economic burden of diabetes has necessitated the development of effective interventions that simplify early diagnosis, promote effective care, and enhance primary prevention [4].
The management of diabetes includes maintaining a healthy lifestyle, such as meal planning, physical activity, and medication adherence. Since healthcare providers are not always present, developing self-management skills is critical for diabetes management. Patient education programs have been implemented to educate patients on their active roles in disease management. These programs were reported to result in a better understanding of patients’ perspectives and attitudes toward health, as well as their compliance with drug decisions, risk factors, and overall quality of life [5]. Although pharmacotherapy is an effective treatment modality to achieve optimal glycemic control and prevent the development of diabetes complications, its efficacy is often limited by poor medication adherence among patients with diabetes. Approximately 43.4% of diabetic patients in low- and middle-income countries do not adhere to their pharmacotherapy treatments [6].
Anzeige
An increasing number and types of intervention strategies are being developed to complement pharmacotherapy in diabetes management. Intervention strategies that aim to promote better disease control include patient-mediated strategies through interactions with patients or via the information provided by or to patients [7]. The types of intervention strategies reported in previous studies include counseling, psychological and social interventions, patient empowerment, patient-centered training, explanation of possible adverse events, nutritional therapy, physical activity, and health coaching [8]. Intervention strategies are introduced based on the capacity and needs at the local level and are provided in combination or as single strategies. In addition, patient-centered services facilitated by multiple healthcare professionals, including pharmacists, have shown to enhance outcomes [9‐11].
Pharmacists who are knowledgeable in pharmacotherapy are well-trained in identifying patients’ pharmaceutical care issues, such as adverse drug reactions and non-adherence. In addition, pharmacists who are working in outpatient and ambulatory care who are more accessible to the community, are well-positioned to educate, monitor, and support medication adherence and self-care of diabetic patients, which may contribute to the achievement of therapeutic success in diabetes management. An example of a pharmacist-led diabetes management service includes a review of medicines that aim to improve patients’ understanding of the disease and increase their adherence to treatment. Several systematic evaluations have been undertaken throughout the years to investigate the impact of pharmacist-led diabetic care [12‐14]. Nonetheless, the studies’ primary focus was on the treatments’ impacts and results, with just a brief mention of the particular tactics and service models delivered. Exploring the specifics of the intervention’s activities and strategies may provide insight into similarities and differences that may or may not have an impact on patient outcomes.
A systematic review by Presley et al. (2018) on interventions to improve medication adherence among adults demonstrated the role of pharmacists in improving diabetes control [8]. In their study, the intervention by pharmacists enhanced diabetes outcomes (standardized mean difference, -0.68; 95% confidence interval, -0.79, -0.58; p < 0.001) with subgroup analysis by intervention strategy, and the type of intervention and outcome measures produced similar results. In their study, nevertheless, the intervention strategies were classified as educational, behavioral, or a combination of both, with an unclear definition of the activities involved. Since many different activities were reported to be provided during pharmacist-led diabetes management services, it is worth exploring and classifying intervention strategies based on their specific activities [8]. In addition, the effectiveness of these two broad intervention strategies was inconsistent between studies in which the best interventions to improve nonadherence could not be determined [8]. Thus, this study aimed to provide a review of the type of individualized intervention strategies and service model provided during pharmacist-led type 2 diabetes management, which includes reviewing specific service content, such as information on the activities involved, delivery methods, settings, frequencies of appointments, and collaborative work with other healthcare providers and their outcomes.
Methods
As the study aimed at providing an overview of the intervention strategies and service model provided during pharmacist-led type 2 diabetes management, scoping review methodology was deemed the most appropriate method to be applied. The current study utilized the scoping review methodology of the Joanna Briggs Institute Reviewers’ Manual 2015 [15]. The manual was one of the latest published on scoping reviews methodology. The step-by-step approach in the manual was well described and provided clear guidance for conducting a scoping review. Articles on pharmacist-led diabetes management focusing on service content, delivery methods, settings, frequencies of appointments, collaborative work with other healthcare providers, and reported outcomes were searched and identified.
Anzeige
Search criteria
Articles were searched from four electronic databases: Ovid Medline, PubMed, Scopus, and Web of Science from 1990 to October 2020. Relevant Medical Subject Headings (MeSH) and keywords such as “diabetes,” “medication adherence,” “blood glucose,” “HbA1c,” and “pharmacist” were used to identify published articles. The specific search strings used for the search can be found in the supplementary material. To increase the specificity and sensitivity of the identified articles, MeSH terms and keywords were combined using the Boolean operator, AND or OR, where appropriate. The reference lists of the retrieved papers were screened for potentially relevant papers that were missing during the electronic search.
Study selection
All retrieved articles were imported to Mendeley, a reference management system software, and duplicates were removed. Articles were included if they had been conducted as a randomized controlled trial; intervention conducted by pharmacists aimed at improving medication adherence and/or glycemic control, including diabetic patients aged 18 and above; and conducted in outpatient or ambulatory settings and reported glycemic control or medication adherence level as the outcomes. Multicomponent team-based care and programs were included if the study defined the program as a pharmacist-led program and the involvement of other healthcare providers are only to address specific issues such as prescribing and meal planning. Only studies with randomized controlled trials (RCTs) study design were included as they usually represent optimal study design and regarded as highest quality evidence. RCTs usually minimize bias in their study procedure and combining RCTs with other study designs may increase study’s heterogeneity, hence, making comparison and conclusion difficult to be made. In addition, randomized controlled trials report usually includes a more detailed information on their intervention programs making it possible for relevant and accurate details to be extracted. Articles were excluded if they had been conducted in a well-controlled environment, such as in a university or academic institution that did not reflect a real practice setting; full articles could not be retrieved; and were not published in the English language.
Articles were initially screened by F.H. based on their title and abstract. The exclusion process using titles or abstracts by F.H. occurred only if the reason for exclusion was clear. If there was uncertainty, the article was not excluded, and each member of the research team (F.H., E.H., A.M.A., C.W.W.) reviewed the article. All excluded “full text” articles were independently reviewed by F.H., E.H., A.M.A., and C.W.W. to ensure the validity of the process. Any disagreements regarding whether a study should be included or excluded were resolved through consensus when the majority indicated their agreement over the matter.
Data extraction
F.H. performed data extraction for all articles, which was checked by E.H. Extracted data included title, year of publication, authors and location of the study, contents of the intervention, delivery approaches, healthcare workers involved, frequency of appointments, follow-up period, and reported outcomes. C.W.W. and A.M.A. reviewed the extracted data in a table form. Discrepancies were discussed and resolved by consensus.
Data analysis
Data analysis was conducted through a narrative synthesis of the articles by evaluating and comparing the pharmacist-led interventions reported in the articles. The results were summarized according to the type of service content, delivery methods and settings, frequency of appointments, collaborative work with other healthcare providers, and outcomes of glycemic control and medication adherence. The types of service content and delivery methods with their definitions were identified from the studies based on the description of activities reported in the articles and are tabulated in the summary table. The code was initially categorized by F.H. and refined by E.H. The final coding was assessed by all team members, F.H., E.H., A.M.A., and C.W.W., and disagreement was resolved through consensus. The current study reported that the glucose control outcome as significant if at least one of the result of the glucose readings measured by the studies (random blood glucose, fasting blood glucose, HbA1c or post-prandial blood glucose) was reported significant.
Results
The systematic search retrieved 4,370 articles located through the electronic database search. After removing duplicates and titles/abstracts that were unrelated to pharmacist-led diabetes management, 140 articles were included in the full-text review. After applying the inclusion and exclusion criteria, 61 articles were included in the analysis. Figure 1 summarizes the PRISMA flow process for the identification, screening, and inclusion of the identified articles.
Fig. 1
Flow chart of the search result
×
All included studies were randomized controlled trials. Studies included were from Australia (n = 2), South America (n = 4), North America (n = 16), Europe (n = 7), Asia (n = 27), and Africa (n = 2). The earliest study was published in 1996, and most studies (n = 48) were published after 2010. Pharmacist interventions on diabetes management were provided in settings, such as community health centers (n = 4), community pharmacies (n = 11), outpatient clinics (n = 44), and outpatient pharmacies (n = 2). Table 1 summarizes the characteristics of the included studies.
Table 1
Summary of studies and description of service model and intervention provided
No.
Author
Country
Year
Location
HCP involvement
Method of delivery
Tools/ Aids
Pharmacist
Multidisciplinary Tteam
Face to face
Phone calls
Group sessions
Home visits
Diaries
Printed materials
Video
Email
Pill box
Games
1
Castejon et al.
USA
2013
Outpatient Pharmacy
x
x
x
x
2
Lim et al.
Malaysia
2016
Outpatient Clinic
x
x
x
3
Ali et al.
UK
2012
Community Pharmacy
x
x
x
4
Venkatesan et al.
India
2012
Community Pharmacy
x
x
x
5
Grant et al.
USA
2003
Community Health Center
x
x
x
6
Ramanath et al.
India
2012
Outpatient Clinic
x
x
x
7
Mahwi et al.
Iraq
2013
Outpatient Clinic
x
x
8
Clifford et al.
Australia
2002
Outpatient Clinic
x
x
9
Phumipamorn et al.
Thailand
2008
Outpatient Clinic
x
x
10
Al Mazroui et al.
UAE
2009
Outpatient Clinic
x
x
x
x
11
Farsaei et al.
Iran
2011
Outpatient Clinic
x
x
x
x
x
12
Mehuys et al.
Belgium
2011
Community Pharmacy
x
x
13
Jacobs et al.
USA
2012
Outpatient Clinic
x
x
14
Jarab et al.
Jordan
2012
Outpatient Clinic
x
x
x
x
15
Odegard et al.
USA
2012
Community Pharmacy
x
x
x
16
Shah et al.
USA
2013
Outpatient Clinic
x
x
17
Chung et al.
Malaysia
2014
Outpatient Clinic
x
x
x
x
18
Jahangard et al.
Iran
2015
Community Pharmacy
x
x
x
x
x
19
Wishah et al.
Jordan
2015
Outpatient Clinic
x
x
x
x
20
Xin et al.
China
2015
Outpatient Clinic
x
x
x
x
x
21
Butt et al.
Malaysia
2016
Outpatient Clinic
x
x
22
Chen et al.
Taiwan
2016
Outpatient Clinic
x
x
x
x
x
23
Aguiar et al.
Brazil
2016
Outpatient Clinic
x
x
x
x
x
24
Chow et al.
Malaysia
2015
Outpatient Clinic
x
x
x
x
x
25
Renuga et al.
India
2016
Outpatient Pharmacy
x
x
x
26
Samtia et al.
India
2013
Outpatient Clinic
x
x
27
Cani et al.
Brazil
2015
Outpatient Clinic
x
x
x
28
Chan et al.
Hong Kong
2012
Outpatient Clinic
x
x
x
29
Abuloha et al.
Jordan
2016
Outpatient Clinic
x
x
x
x
30
Choe et al.
USA
2005
Outpatient Clinic
x
x
x
31
Clifford et al.
Australia
2005
Outpatient Clinic
x
x
x
32
Cohen et al.
USA
2011
Outpatient Clinic
x
x
x
x
33
Doucette et al.
USA
2009
Community Pharmacy
x
x
34
Fornos et al.
Spain
2006
Community Pharmacy
x
x
x
35
Ghosh et al.
India
2010
Outpatient Clinic
x
x
x
36
Jaber et al.
USA
1996
Outpatient Clinic
x
x
37
Kraemer et al.
USA
2012
Community Health Centre
x
x
38
Mourao et al.
Brazil
2013
Outpatient Clinic
x
x
39
Plaster et al.
Brazil
2012
Outpatient Clinic
x
x
x
x
40
Sriram et al.
India
2011
Outpatient Clinic
x
x
x
x
x
41
Taveira et al.
USA
2010
Outpatient Clinic
x
x
42
Jameson et al.
USA
2010
Outpatient Clinic
x
x
x
43
Odegard et al.
USA
2005
Outpatient Clinic
x
x
x
44
Kirwin et al.
USA
2010
Outpatient Clinic
x
x
45
Lyons et al.
UK
2016
Community Pharmacy
x
x
x
46
Malathy et al.
India
2011
Outpatient Clinic
x
x
x
47
Rothman et al.
USA
2005
Outpatient Clinic
x
x
x
48
Sarkadi & Rosenqvist et al.
Sweden
2004
Community Health Center
x
x
x
x
x
49
Scott et al.
USA
2006
Community Health Center
x
x
x
x
50
Adepu et al.
India
2007
Community Pharmacy
x
x
x
51
Erku et al.
Ethiopia
2017
Outpatient Clinic
x
x
x
52
Korcegez et
Cyprus
2017
Outpatient Clinic
x
x
x
53
Ojieabu et
Nigeria
2017
Outpatient Clinic
x
x
x
54
Shao et al.
China
2017
Outpatient Clinic
x
x
x
55
Lauffenburger et al.
USA
2019
Outpatient
x
x
x
56
Wu et al.
USA
2018
Outpatient Clinic
x
x
57
Michiels et al.
France
2019
Community Pharmacy
x
x
x
58
Javaid et al.
Pakistan
2019
Outpatient Clinic
x
x
59
Withidpanyawong et al.
Thailand
2018
Outpatient Clinic
x
x
60
Sarayani et al.
Iran
2018
Community Pharmacy
x
x
61
Ayadurai et al.
Malaysia
2018
Outpatient Clinic
x
x
No.
Author
Country
Year
Location
Content
Outcome
Diabetes education
Medication review
Drug counselling
Clinical intervention
Lifestyle adjustment
Self care
Peer support
Behavioural intervention
Glucose control
Adherence
1
Castejon et al.
USA
2013
Outpatient Pharmacy
x
x
x
x
I > C
2
Lim et al.
Malaysia
2016
Outpatient Clinic
x
x
I > C
I > C
3
Ali et al.
UK
2012
Community Pharmacy
x
x
I > C
4
Venkatesan et al.
India
2012
Community Pharmacy
x
x
x
x
NS
5
Grant et al.
USA
2003
Community Health Center
x
NS
NS
6
Ramanath et al.
India
2012
Outpatient Clinic
x
I > C
I > C
7
Mahwi et al.
Iraq
2013
Outpatient Clinic
x
x
I > C
I > C
8
Clifford et al.
Australia
2002
Outpatient Clinic
x
NS
9
Phumipamorn et al.
Thailand
2008
Outpatient Clinic
x
x
x
I > C
I > C
10
Al Mazroui et al.
UAE
2009
Outpatient Clinic
x
x
x
I > C
11
Farsaei et al.
Iran
2011
Outpatient Clinic
x
x
x
x
I > C
12
Mehuys et al.
Belgium
2011
Community Pharmacy
x
x
x
I > C
13
Jacobs et al.
USA
2012
Outpatient Clinic
x
x
x
x
I > C
14
Jarab et al.
Jordan
2012
Outpatient Clinic
x
x
x
x
I > C
15
Odegard et al.
USA
2012
Community Pharmacy
x
x
I > C
16
Shah et al.
USA
2013
Outpatient Clinic
x
x
I > C
I > C
17
Chung et al.
Malaysia
2014
Outpatient Clinic
x
x
x
I > C
I > C
18
Jahangard et al.
Iran
2015
Community Pharmacy
x
x
x
NS
I > C
19
Wishah et al.
Jordan
2015
Outpatient Clinic
x
x
x
I > C
20
Xin et al.
China
2015
Outpatient Clinic
x
I > C
I > C
21
Butt et al.
Malaysia
2016
Outpatient Clinic
x
x
x
x
I > C
I > C
22
Chen et al.
Taiwan
2016
Outpatient Clinic
x
x
I > C
23
Aguiar et al.
Brazil
2016
Outpatient Clinic
x
x
x
I > C
I > C
24
Chow et al.
Malaysia
2015
Outpatient Clinic
x
x
x
I > C
I > C
25
Renuga et al.
India
2016
Outpatient Pharmacy
x
I > C
I > C
26
Samtia et al.
India
2013
Outpatient Clinic
x
x
x
NS
I > C
27
Cani et al.
Brazil
2015
Outpatient Clinic
x
x
x
x
x
NS
I > C
28
Chan et al.
Hong Kong
2012
Outpatient Clinic
x
x
I > C
I > C
29
Abuloha et al.
Jordan
2016
Outpatient Clinic
x
x
x
x
I > C
30
Choe et al.
USA
2005
Outpatient Clinic
x
x
x
x
I > C
31
Clifford et al.
Australia
2005
Outpatient Clinic
x
x
x
I > C
32
Cohen et al.
USA
2011
Outpatient Clinic
x
x
x
x
NS
33
Doucette et al.
USA
2009
Community Pharmacy
x
x
x
NS
34
Fornos et al.
Spain
2006
Community Pharmacy
x
x
I > C
35
Ghosh et al.
India
2010
Outpatient Clinic
x
x
x
I > C
36
Jaber et al.
USA
1996
Outpatient Clinic
x
x
x
x
I > C
37
Kraemer et al.
USA
2012
Community Health Centre
x
x
x
NS
38
Mourao et al.
Brazil
2013
Outpatient Clinic
x
x
x
x
I > C
39
Plaster et al.
Brazil
2012
Outpatient Clinic
x
x
I > C
40
Sriram et al.
India
2011
Outpatient Clinic
x
x
I > C
41
Taveira et al.
USA
2010
Outpatient Clinic
x
x
x
x
x
x
I > C
42
Jameson et al.
USA
2010
Outpatient Clinic
x
x
x
x
NS
43
Odegard et al.
USA
2005
Outpatient Clinic
x
NS
44
Kirwin et al.
USA
2010
Outpatient Clinic
x
x
NS
45
Lyons et al.
UK
2016
Community Pharmacy
x
NS
I > C
46
Malathy et al.
India
2011
Outpatient Clinic
x
x
NS
47
Rothman et al.
USA
2005
Outpatient Clinic
x
x
x
x
NS
48
Sarkadi & Rosenqvist et al.
Sweden
2004
Community Health Center
x
x
x
I > C
49
Scott et al.
USA
2006
Community Health Center
x
x
x
x
I > C
50
Adepu et al.
India
2007
Community Pharmacy
x
x
x
NS
51
Erku et al.
Ethiopia
2017
Outpatient Clinic
x
x
x
I > C
52
Korcegez et
Cyprus
2017
Outpatient Clinic
x
x
x
x
x
I > C
I > C
53
Ojieabu et
Nigeria
2017
Outpatient Clinic
x
x
I > C
I > C
54
Shao et al.
China
2017
Outpatient Clinic
x
x
x
I > C
I > C
55
Lauffenburger et al.
USA
2019
Outpatient
x
x
NS
NS
56
Wu et al.
USA
2018
Outpatient Clinic
x
x
x
x
NS
57
Michiels et al.
France
2019
Community Pharmacy
x
x
I > C
NS
58
Javaid et al.
Pakistan
2019
Outpatient Clinic
x
x
x
x
I > C
59
Withidpanyawong et al.
Thailand
2018
Outpatient Clinic
x
x
I > C
I > C
60
Sarayani et al.
Iran
2018
Community Pharmacy
x
x
NS
I > C
61
Ayadurai et al.
Malaysia
2018
Outpatient Clinic
x
x
x
I > C
Anzeige
Most interventions were conducted by multidisciplinary teams of healthcare providers, including pharmacists, doctors, nurses, dietitians, and diabetes educators (n = 37). Only 24 of the included studies contained interventions performed solely by pharmacists. In such settings, the interventions conducted by pharmacists, which are rarely clinical interventions, include diabetes education, medication review, drug counselling, self-care recommendations, and lifestyle adjustments.
The method of service delivery included face-to-face sessions with individual patients, which was the most common method used (n = 51), scheduled telephone calls (n = 27), group sessions (n = 8), and visits to patients’ homes (n = 2). Fifteen studies used face-to-face meetings as the single method to deliver interventions [16‐30]. Another four studies utilized single delivery group sessions [31‐33] and phone calls [34] to deliver interventions. Three studies used a combination of three intervention delivery methods [35‐37]. The most common combination of delivery methods was face to face meeting and phone calls (n = 22) [35, 37‐56]. During the interventions, several delivery aids were used, such as videos (n = 2), printed materials consisting of a summary of important information for patients (n = 20), email reminders (n = 1), patient diaries (n = 11), and pillboxes (n = 6).
Eight intervention strategy categories were identified in the included studies. Table 2 provides a detailed description of the categories and potential activities involved. Intervention strategies were categorized into diabetes education, medication review, drug consultation/counseling, clinical intervention, lifestyle adjustment, self-care, peer support, and behavioral intervention. The most popular strategy for this was diabetes education. The educational components of these interventions primarily aimed to increase the patients’ general understanding of their condition by discussing the expected degree of diabetic control, risk of complications, and ways to minimize these risks [57]. Patients were also informed about the types of medications used to treat their disease [58].
Table 2
Description of intervention categorization and potential activities involved
Intervention categories
Description of intervention
Example of activities involved
References
Diabetes education
Provide the patient with adequate knowledge about diabetes and skills they need to manage their clinical condition and lifestyle.
Educational videos, pamphlets, educational websites, power point presentations, face-to-face/group teaching sessions.
Pharmacists addressed issues pertaining to medication optimization and adherence, hence enhancing the therapeutic efficacy of drugs administered to patients.
Review of patients’ medications, arrangements of drug taking schedules, discussion and evaluation of medication regimens, dose up-titrations per pre-established protocols without prescriber’s involvement.
A collaborative intervention with the prescriber on drug related problems requiring clinical interventions such as regimen changes or dosage adjustment.
Evaluation and adjustment of patients’ medication with the involvement of the prescribers.
Promotes communications and sharing of knowledge and experience between patients that have poor control of diabetes with patients that already have better experience in managing their disease.
Participation of family members, friends, and other sources of social support in the intervention program.
Only seven studies utilized a single intervention strategy, which included diabetes education [17, 35, 59, 60], medication review [37], and drug consultation/counseling [61, 62]. Most studies incorporated two or more intervention strategy categories. In particular, 17 combined two strategies [16, 28, 33, 34, 36, 39, 41, 45, 48, 55, 63‐66], 18 combined three [18, 19, 23, 24, 26, 30, 38, 44, 46, 50, 51, 53, 54, 67‐71], 16 combined four [20, 22, 25, 27, 29, 32, 37, 42, 43, 47, 49, 52, 56, 72‐74], 2 combined five [75, 76], and 1 combined six [31]. The most commonly utilized intervention strategy was diabetes education (n = 49), whereas the least utilized service content category was peer support (n = 1).
The follow-up periods of the pharmacists’ interventions differed in each study and ranged between 1.5 [67] and 24 months [42]. One study followed up patient for 2 months [59], nine for 3 months [16, 52, 53, 56, 60, 61, 64, 70, 74], five for 4 months [21, 25, 31, 45, 68], three for 5 months [23, 50, 53], fourteen for 6 months [22, 27, 30, 36, 39, 40, 44, 46, 49, 62, 73, 75], three for 8 months [18, 55, 72], four for 9 months [29, 33, 37, 41], eighteen for 12 months [20, 24, 26, 28, 35, 38, 43, 47, 48, 51, 54, 63, 65, 66, 69, 71, 76, 77], one for 13 months [32] and another one for 16 months [10]. The most common follow-up period for the interventions was 12 months (n = 19, 31.1%), and the mean intervention duration was 7.8 months.
The frequency of follow-up varied from a minimum of a single follow-up [21, 28, 61, 69] to 24 follow-ups [42]. Five studies set a frequency of two follow-ups [44, 48, 59, 62, 68], twelve set three follow-ups [16, 20, 22, 29, 49, 52, 60, 64, 65, 70, 72, 74], five set four follow-ups [17, 18, 24, 31, 45], two set five follow-ups [53, 76], eleven set six follow-ups [19, 26, 27, 30, 33, 36, 39, 54, 67, 75, 77], four set eight follow-ups [10, 32, 37, 38], another four set nine follow-ups [40, 46, 66, 73], one set ten follow-ups [25], and six set twelve follow-ups [35, 43, 51, 56, 63, 71]. Five of the studies did not describe the number of follow-ups carried out in detail [23, 41, 47, 50, 55]. The mean number of follow-ups that the patients received was six. The most common number of follow-ups reported by the studies was three (n = 13, 21.43%).
Most studies (n = 36) reported glucose control as the outcome, 24 reported glucose control and medication adherence as the outcomes, and one study reported medication adherence as the outcome. Most studies (n = 41) also showed significant improvement in glucose control, which was measured by glycosylated hemoglobin, fasting or random blood glucose levels, or a combination of these. Meanwhile, 22 of the 25 studies reported significant improvement in medication adherence measured using the eight-item Morisky Scale, Malaysian Medication Adherence Scale, pill-count, self-reported adherence scale, dispensing history, diagnostic adherence to medication scale, or Morisky Green Levine Medication Adherence Scale.
Anzeige
Discussion
The current scoping review aimed to evaluate the type of interventions and service model provided during the provision of pharmacist-led type 2 diabetes management which previously had unclear classification with no detail on the activities involved. This includes a review of the type of service content, delivery methods, settings, frequencies of appointments, collaborative work with other healthcare providers, and reported outcomes. Pharmacist-led diabetes interventions were provided in six continents, with most studies (n = 37) conducted in Asia. This was not surprising since the highest prevalence of diabetes is found in Asian countries [1]. Thirty of the studies were conducted in high-income countries, one in low-income country, 13 in lower-middle-income countries, and 17 in upper-middle-income countries. There is a lack of interest in the topic in low-income countries even though the prevalence of non-adherence towards treatment is high and the promotion of effective treatment plan would help reduce the burden of diabetes management in such countries [4, 6]. Most services (n = 37) were provided by a multidisciplinary health care team, and only a few (n = 24) were conducted solely by pharmacists. Nevertheless, in these studies, most showed that pharmacists also worked directly with a physician on patient issues, for example, if the patient required approval for prescription adjustment and specific diet plan such as fasting. A meta-analysis study on the multidisciplinary team approach to coordinated pharmaceutical care found that such collaborations reduced the likelihood of patients’ hospitalization and increased their quality of life [78].
Face-to-face sessions were the most common method for pharmacist-led diabetes management reported in the included studies. This traditional method of service delivery is well established and generally well accepted by patients. Most studies reported good patient retention throughout the study period. However, unlike in a trial environment, patients in a real-world setting may not be able to complete proper follow-ups with frequent face-to-face appointments. In clinical trials, patients are routinely reminded to attend their subsequent appointments and are often rewarded with tokens for their participation in the trials. Therefore, they might have different motivations for retaining themselves in the program compared to actual patients outside clinical trial settings. For example, in a diabetes prevention program in England involving 100,000 patients, only 22% of the participants completed the program [79]. Therefore, it is important to review an intervention program beyond the “controlled” environment and ensure its convenience for the patient. Providing more interventions through phone calls and video conferences should be explored in the future, as they are generally equally effective as face-to-face sessions [80]. Home visits may suit patients with logistics issues who require frequent clinic visits. Meanwhile, group sessions may be useful for behavioral interventions that include peer support and mentoring activities [81].
Eight categories of pharmacist-led service contents were identified from the reported studies, which included diabetes education, medication review, drug consultation/counseling, clinical intervention, lifestyle adjustment, self-care, peer support, and behavioral intervention. The majority of the studies combined two or more service content categories for intervention. Although the best combination of interventions for diabetes management could not be determined due to an inconsistency in the services provided across the studies, combining several types of intervention content was found to be more effective than a single intervention [8, 82]. Studies have shown that a combination of services improves patients’ medication adherence and glucose control. In the current study, diabetes education prevailed as the most common intervention in pharmacist-led diabetes services, with the aim of providing patients with the knowledge and skills needed to manage their clinical condition and lifestyle. Previous systematic reviews also found that diabetes education was most effective in improving diabetes control and enhancing medication adherence [8, 57, 58, 82]. During diabetes education, printed or digital materials and training or group discussions can also be considered, as they were also reported to be equally effective [8].
In the current study, medication review was the second intervention widely used during pharmacist-led diabetes management. During medication review, pharmacists optimize patients’ medications and ensure their adherence [83]. Medication review is one of the most effective tools for improving patient clinical outcomes and safety by resolving treatment complexities. Several systematic reviews have reported that medication reviews in the care of diabetic patients have improved clinical results and provided favorable economic outcomes that are not only beneficial to the self-paying patients, but also to the healthcare system [84, 85]. Other service interventions include self-care content, such as self-blood glucose monitoring and foot care; lifestyle adjustments, such as eating habits and physical exercise; drug consultation or counseling that focuses on effective use of medications; clinical intervention that includes a change in regimen or dosing adjustment that was carried out after agreement with the prescriber; and behavior-change content, such as goal-setting, cognitive behavioral therapy, and problem solving. The majority of the studies employed a variety of terminology to name their intervention techniques. This makes determining the types of specific intervention delivered challenging. A list of standardized terminologies and their meanings would be extremely valuable for practice harmonization and guaranteeing that future intervention program outcomes may be compared in a more methodical and meaningful manner.
The current study found that the duration and frequency of pharmacist-led diabetic interventions varied between the studies. A previous review found that studies with longer follow-up periods were associated with better outcomes [8]. Nevertheless, most included studies had good patient retention rates throughout the study period, which could differ in actual practice; the reason for the difference could be due to the “controlled environment” in the trial setting, in which patients were closely followed up. The same study also reported that pharmacist interventions significantly improved most of the outcome measures within three follow-up visits [8]. Hence, the delivery of content should be based on the patient’s immediate needs and should not be too structured in the view that patients may not return for their next appointment. In addition, no consistent pattern was found between intervention categories and patient outcomes. This would be difficult to identify because the majority of the included studies reported significant improvements in glucose control and medication adherence.
This study has a few limitations. Firstly, since the intended purpose of a this scoping review is to gather information on type of intervention strategies provided during pharmacist-led diabetes management, as opposed to recommending a clinical practice, quality assessment is not undertaken hence, making it impossible for any implications for practice or policy to be graded. The components of the interventions and their categorization were based on the information provided in the manuscript. Some interventions were not sufficiently explained, which may have caused limitations in the intervention categorization. However, we independently checked the assigned categories and ensured that the intervention components were identified appropriately. In addition, most included studies reported significant findings on glucose control and improvement in medication adherence, making it difficult to evaluate the effectiveness of individual intervention categories. The risk of bias assessment was not done to evaluate the study quality, as this study aimed only to provide an overview of intervention categories according to the activities described in the study.
Conclusion
Variations in intervention strategies were found in the reported studies, with the most used being diabetes education and medication review. Most studies used a combination of two or more intervention strategy categories when providing services, with no specific pattern found between the service model and patient outcomes. A standardization of terminologies used for future pharmacist-led diabetes management services should be encouraged to ensure harmonization in the service, and making it possible for more research to systematically explore the effectiveness of individual or combination of intervention strategies provided.
Acknowledgements
We would like to thank the Quality Management of Medicines Research Group, Faculty of Pharmacy, Universiti Kebangsaan Malaysia for providing support for this study. We would also like to thank Ministry of Health Malaysia and Public Services Division Malaysia for awarding study scholarship (Hadiah Latihan Persekutuan) for FH.
Declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
